CUHK_CCT00016
2005-09-05
Retrospective
Chinese University of Hong Kong Institute of Chinese Medicine; Chinese University of Hong Kong; and BUPA Foundation
The Chinese University of Hong Kong
Kwong Wah Hospital
Fion Yip
Tel or Tel [852] 26323593
email or Email fionyip@cuhk.edu.hk
Larry Baum
Tel or Tel [852] 26323146
email or Email lwbaum@cuhk.edu.hk
A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
Curcumin for AD
Yes
2003-04-23
Nervous System Diseases
Drug
Curcumin and ginkgo extract
6 months
Placebo
Inclusion: Possible or probable AD.
Exclusion: Anticoagulant or antiplatelet treatment or bleeding risk factors; currently smoking; or other severe illness.
Randomized
Placebo
Double-blind
Parallel
2004-10-07
30
Recruiting
Setting up formulation, patient recruitment, and assay procedures at 0, 1, and 6 months, in preparation for a later clinical trial testing the effectiveness of curcumin and ginkgo in slowing AD progression.
Change in biochemical measures of AD: Plasma isoprostane and A-beta levels at 1 and 6 months. Change in cognitive measures of AD: MMSE at 6 months. Change in others: cholesterol, lipid, C reactive protein, and metal levels in serum at 1 and 6 months. Curcumin and metabolites at 1 month.
2011-03-02
ChiCTR-TRC-09000626
2010-05-04
Yes
|
|
|
|
|
---|---|---|---|---|
No documents yet. |